European Shorting
ARIA has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
ARIA has been removed from your Stock Email Alerts list.
Also See GuruFocus Insider Trade Screener:
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned Following This | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Details |
|---|---|---|---|---|---|---|---|---|---|
| BERGER HARVEY J M D | Chairman & CEO (Click for the stocks that their CEOs have bought) | 2013-05-15 | Sell | 92,498 | 3,516,776 | $18.1 | 1674.2 | -3.15 | Link |
| BERGER HARVEY J M D | Chairman & CEO | 2013-04-17 | Sell | 105,400 | 3,672,860 | $18.01 | 1898.3 | -2.67 | Link |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 2013-04-02 | Sell | 2,400 | 117,871 | $18.05 | 43.3 | -2.88 | Link |
| BERSTEIN DAVID L | Senior VP, Chief IP Officer | 2013-04-02 | Sell | 2,400 | 208,898 | $18.05 | 43.3 | -2.88 | Link |
| FITZGERALD EDWARD M | Executive VP, CFO | 2013-04-02 | Sell | 5,200 | 199,355 | $18.04 | 93.8 | -2.83 | Link |
| DODION PIERRE F | SVP, Corp. Dev. & Operations | 2013-04-02 | Sell | 2,400 | 57,682 | $18.04 | 43.3 | -2.83 | Link |
| CLACKSON TIMOTHY P | President, R&D, CSO | 2013-04-02 | Sell | 6,500 | 363,705 | $18.04 | 117.3 | -2.83 | Link |
| Cantor Maria E | SVP, Corporate Affairs | 2013-04-02 | Sell | 4,250 | 62,275 | $18.04 | 76.7 | -2.83 | Link |
| Haluska Frank | SVP, Clinical R&D, CMO | 2013-04-02 | Sell | 3,400 | 73,907 | $18.04 | 61.3 | -2.83 | Link |
| Keane Raymond T | SVP General Counsel & CCO | 2013-04-02 | Sell | 2,583 | 54,096 | $18.05 | 46.6 | -2.88 | Link |
| FITZGERALD EDWARD M | Executive VP, CFO | 2013-03-26 | Sell | 12,933 | 191,555 | $18.75 | 242.5 | -6.51 | Link |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 2013-03-25 | Sell | 12,933 | 114,271 | $18.87 | 244 | -7.1 | Link |
| CLACKSON TIMOTHY P | President, R&D, CSO | 2013-03-25 | Sell | 19,167 | 357,205 | $18.87 | 361.7 | -7.1 | Link |
| Haluska Frank | SVP, Clinical R&D, CMO | 2013-03-25 | Sell | 5,333 | 68,807 | $18.88 | 100.7 | -7.15 | Link |
| BERSTEIN DAVID L | Senior VP, Chief IP Officer | 2013-03-25 | Sell | 10,533 | 205,298 | $18.87 | 198.8 | -7.1 | Link |
| DODION PIERRE F | SVP, Corp. Dev. & Operations | 2013-03-25 | Sell | 8,133 | 54,082 | $18.87 | 153.5 | -7.1 | Link |
| Keane Raymond T | SVP General Counsel & CCO | 2013-03-25 | Sell | 13,167 | 51,513 | $18.87 | 248.5 | -7.1 | Link |
| Duvall Martin J | SVP, Commercial Operations | 2013-03-22 | Sell | 576 | 2,854 | $19.53 | 11.2 | -10.24 | Link |
| Haluska Frank | SVP, Clinical R&D, CMO | 2013-03-22 | Sell | 2,400 | 60,807 | $19.46 | 46.7 | -9.92 | Link |
| DODION PIERRE F | SVP, Corp. Dev. & Operations | 2013-03-22 | Sell | 2,400 | 41,882 | $19.46 | 46.7 | -9.92 | Link |
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.
Feedback
My Portfolios
Browse Gurus
Bookmark
Add to Portfolio
Get Email Alerts
RSS Update
Company Website
SEC Reports
RSS